To view more news and media here in our Newsroom

Click Here

Study: Cancer Drug Restores Important Brain Dopamine in Parkinson’s Patients

A small phase I study provides molecular evidence that an FDA-approved drug for leukemia significantly increased brain dopamine and reduced toxic proteins linked to disease progression in patients with Parkinson’s disease or dementia with Lewy bodies.

Read More

MedStar Georgetown’s First Living Donor Kidney Recipient Gets Second Transplant - 40 Years Later

Maryland Woman Celebrates Four Decades of Transplant Progress for Donors and Recipients.

Read More

Precision Medicine Clinical Trial for Metastatic Pancreatic Cancer Now Open at Georgetown Lombardi

The first clinical trial to compare standard of care chemotherapy with molecularly tailored therapy (also known as precision medicine) for metastatic pancreatic cancer is now enrolling patients at Georgetown Lombardi Comprehensive Cancer Center.

Read More

MedStar Georgetown Transplant Institute Participates in White House Organ Summit

Three physicians from the MedStar Georgetown Transplant Institute traveled to the White House today for the Obama Administration’s Organ Summit aimed at setting new strategies to increase access to organ transplants and shorten the organ waiting list.

Read More

Top News
Study: Cancer Drug Restores Important Brain Dopamine in Parkinson’s Patients
News
Study: Cancer Drug Restores Important Brain Dopamine in Parkinson’s…
Close
What can we
Help you Find?

Begin your search for a physician, service or location.

Find a Doctor

Start looking for the right physician to meet your health needs.

Call Us Today

Schedule an appointment or get more information about our services.

855-MED-0364

Contact Us

For access to unsurpassed health care treatment, contact us now.